Glooko, Inc., which has developed a software-as-a-service application and accompanying mobile app for diabetes management, announced on 16 March it raised $30m in a series D round of financing, bringing its total funding to $115m.
Glooko’s CEO Russ Johannesson told Medtech Insight the company will use the proceeds to grow the business by expanding its sales and marketing groups and take advantage of the global...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?